Showing 6,621 - 6,640 results of 7,608 for search '"oncology"', query time: 0.08s Refine Results
  1. 6621
  2. 6622

    The optimal treatment of invasive ductal and lobular carcinoma occurring at the same time needs to be established by Supriya Peshin, Rafi Iftekher, Rabia Iqbal, Shagun Singh, Moka Nagaishwarya

    Published 2025-01-01
    “…The case highlights the need for further research into the optimal treatment strategies for synchronous breast cancers, a potential knowledge gap in current oncology practice. A literature review revealed limited reports addressing similar cases, underscoring the lack of consensus guidelines. …”
    Get full text
    Article
  3. 6623
  4. 6624
  5. 6625
  6. 6626
  7. 6627
  8. 6628
  9. 6629
  10. 6630
  11. 6631
  12. 6632
  13. 6633

    An innovative approach to hospital-wide interprofessional capacity building: Côte d’Ivoire National Cancer Center project by Jiyoung Han, Innocent Adoubi, Mee Joo Kang, Sarang Lee, So-Youn Jung, Chong Woo Yoo

    Published 2025-01-01
    “…As a part of The National Radiotherapy and Medical Oncology Center Project in Côte d’Ivoire, the National Cancer Center Korea has initiated a training project for hospital personnel in Côte d’Ivoire. …”
    Get full text
    Article
  14. 6634

    The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors by Xin Y, Liu N, Peng G, Huang X, Cao X, Zhou X

    Published 2025-01-01
    “…Yujing Xin,1 Ning Liu,2 Gang Peng,3 Xiaoyu Huang,3 Xiaojing Cao,3 Xiang Zhou3 1Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People’s Republic of China; 2School of Software, Shandong University, Jinan, Shandong, 250101, People’s Republic of China; 3National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People’s Republic of ChinaCorrespondence: Xiang Zhou, Email zhou.xiang@yeah.netPurpose: To investigate the prognostic value of inflammatory indexes based on peripheral blood cells in unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib combined with PD-1 inhibitors.Methods: This study retrospectively collected baseline inflammatory indexes from HCC patients received Lenvatinib and PD-1 inhibitor-based combination therapy at the Cancer Hospital of the Chinese Academy of Medical Sciences between October 2018 and October 2021. …”
    Get full text
    Article
  15. 6635
  16. 6636
  17. 6637
  18. 6638
  19. 6639
  20. 6640